trans-1,4-bis(2-chlorobenzaminomethyl)cyclohexane dihydrochloride has been researched along with 17-alpha-hydroxyprogesterone in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cerra, B; Gatticchi, L; Gioiello, A; Macchioni, L; Roberti, R; Scarpelli, P; Sebastiani, B | 1 |
1 other study(ies) available for trans-1,4-bis(2-chlorobenzaminomethyl)cyclohexane dihydrochloride and 17-alpha-hydroxyprogesterone
Article | Year |
---|---|
Selected cholesterol biosynthesis inhibitors produce accumulation of the intermediate FF-MAS that targets nucleus and activates LXRα in HepG2 cells.
Topics: 17-alpha-Hydroxyprogesterone; Cell Line; Cell Line, Tumor; Cell Nucleus; Cell Proliferation; Cholestenes; Cholesterol; HEK293 Cells; HeLa Cells; Hep G2 Cells; Humans; Lipid Droplets; Lipids; Liver X Receptors; Receptors, Cytoplasmic and Nuclear; Signal Transduction; trans-1,4-Bis(2-chlorobenzaminomethyl)cyclohexane Dihydrochloride | 2017 |